Addus HomeCare Corporation

NasdaqGS:ADUS Voorraadrapport

Marktkapitalisatie: US$2.1b

Addus HomeCare (ADUS) Aandelenoverzicht

Addus HomeCare Corporation verleent samen met haar dochterondernemingen persoonlijke verzorging aan ouderen, chronisch zieken, gehandicapten en personen die het risico lopen opgenomen te worden in een ziekenhuis of in een instelling in de Verenigde Staten. Meer informatie

Beloningen

Verhandeld tegen 55% onder onze schatting van de reële waarde

De winst zal naar verwachting met 13.64% per jaar groeien

De winst groeide het afgelopen jaar met 20.3%

Risicoanalyse

Aanzienlijke insider-verkoop in de afgelopen 3 maanden


ADUS Community Fair Values

Create Narrative

See what 9 others think this stock is worth. Follow their fair value or set your own to get alerts.

INBS logo
Intelligent Bio Solutions
JO
Jolt_Communications
Community Contributor

The Future of Drug Testing? Fingerprint Tech Shows Serious Promise

Key Takeaways Intelligent Bio Solutions has a new way to test for drugs using fingerprints: it’s quick, portable, and doesn’t require pee cups or saliva swabs. With commercial traction in 24 countries and over 450 active accounts, INBS is now targeting the U.S. market, where over 55 million drug tests are performed annually.
View narrative
US$2.98
FV
42.3% ondergewaardeerd intrinsieke korting
59.20%
Revenue growth p.a.
8users have liked this narrative
0users have commented on this narrative
39users have followed this narrative
25 days ago author updated this narrative
ADUS logo
Addus HomeCare
AN
AnalystLowTarget
Consensus Narrative from 11 Analysts

Rising Wage Costs And Reimbursement Cuts Will Strain Home Healthcare

Key Takeaways Heavy dependence on government reimbursements and industry shifts expose the company to unpredictable revenues, margin compression, and erosion of long-term profitability. Accelerating competition, wage inflation, and technological disruption threaten operational stability and risk diminishing Addus’s competitive position versus more innovative, integrated peers.
View narrative
US$96.53
FV
19.3% overgewaardeerd intrinsieke korting
8.83%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
5 days ago author updated this narrative
ADUS logo
Addus HomeCare
AN
AnalystConsensusTarget
Consensus Narrative from 11 Analysts

Acquiring Gentiva Personal Care Will Enable Comprehensive Home-Based Care Services

Key Takeaways Strategic acquisitions and synergies are expected to enhance revenue growth, EBITDA contributions, and broaden service offerings for Addus HomeCare. Rate increases and operational improvements are poised to drive organic growth, improve margins, and enhance overall earnings.
View narrative
US$126.57
FV
9.0% ondergewaardeerd intrinsieke korting
11.52%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
5 days ago author updated this narrative
ADUS logo
Addus HomeCare
AN
AnalystHighTarget
Consensus Narrative from 11 Analysts

Aging America And Value-Based Care Will Fuel Home Care Opportunities

Key Takeaways Strong demand, regulatory support, and successful acquisitions drive sustained revenue growth, margin expansion, and EPS acceleration across key personal care and hospice segments. Strategic investments in digital tools and workforce efficiency, alongside a healthy balance sheet, enable continued expansion and improved operating performance.
View narrative
US$160.00
FV
28.0% ondergewaardeerd intrinsieke korting
12.97%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
12 days ago author updated this narrative
View Addus HomeCare Community

Addus HomeCare Corporation Concurrenten

Prijsgeschiedenis en prestaties

Overzicht van hoogtepunten, dieptepunten en veranderingen in de aandelenkoersen voor Addus HomeCare
Historische aandelenkoersen
Huidige aandelenkoersUS$115.19
52 Week HoogtepuntUS$136.72
52 Week LaagUS$88.96
Bèta0.81
1 maand verandering3.86%
3 maanden verandering16.44%
1 Jaar Verandering-0.84%
3 jaar verandering36.13%
5 jaar verandering27.49%
Verandering sinds IPO1,256.77%

Recent nieuws en updates

Are Investors Undervaluing Addus HomeCare Corporation (NASDAQ:ADUS) By 41%?

May 28
Are Investors Undervaluing Addus HomeCare Corporation (NASDAQ:ADUS) By 41%?

Additional Considerations Required While Assessing Addus HomeCare's (NASDAQ:ADUS) Strong Earnings

May 14
Additional Considerations Required While Assessing Addus HomeCare's (NASDAQ:ADUS) Strong Earnings

Recent updates

Are Investors Undervaluing Addus HomeCare Corporation (NASDAQ:ADUS) By 41%?

May 28
Are Investors Undervaluing Addus HomeCare Corporation (NASDAQ:ADUS) By 41%?

Additional Considerations Required While Assessing Addus HomeCare's (NASDAQ:ADUS) Strong Earnings

May 14
Additional Considerations Required While Assessing Addus HomeCare's (NASDAQ:ADUS) Strong Earnings

Addus HomeCare: A Cautious Hold

Apr 07

Addus HomeCare (NASDAQ:ADUS) Has A Rock Solid Balance Sheet

Mar 13
Addus HomeCare (NASDAQ:ADUS) Has A Rock Solid Balance Sheet

Addus HomeCare Corporation's (NASDAQ:ADUS) Stock Retreats 25% But Earnings Haven't Escaped The Attention Of Investors

Feb 26
Addus HomeCare Corporation's (NASDAQ:ADUS) Stock Retreats 25% But Earnings Haven't Escaped The Attention Of Investors

Addus HomeCare (NASDAQ:ADUS) Shareholders Will Want The ROCE Trajectory To Continue

Feb 25
Addus HomeCare (NASDAQ:ADUS) Shareholders Will Want The ROCE Trajectory To Continue

Is There Now An Opportunity In Addus HomeCare Corporation (NASDAQ:ADUS)?

Feb 12
Is There Now An Opportunity In Addus HomeCare Corporation (NASDAQ:ADUS)?

A Look At The Intrinsic Value Of Addus HomeCare Corporation (NASDAQ:ADUS)

Jan 29
A Look At The Intrinsic Value Of Addus HomeCare Corporation (NASDAQ:ADUS)

Addus HomeCare: Growth Capitalized At Higher Multiples

Dec 25

Addus HomeCare (NASDAQ:ADUS) Ticks All The Boxes When It Comes To Earnings Growth

Dec 14
Addus HomeCare (NASDAQ:ADUS) Ticks All The Boxes When It Comes To Earnings Growth

When Should You Buy Addus HomeCare Corporation (NASDAQ:ADUS)?

Oct 31
When Should You Buy Addus HomeCare Corporation (NASDAQ:ADUS)?

Addus HomeCare's (NASDAQ:ADUS) Returns On Capital Are Heading Higher

Oct 15
Addus HomeCare's (NASDAQ:ADUS) Returns On Capital Are Heading Higher

A Look At The Fair Value Of Addus HomeCare Corporation (NASDAQ:ADUS)

Oct 02
A Look At The Fair Value Of Addus HomeCare Corporation (NASDAQ:ADUS)

Some Confidence Is Lacking In Addus HomeCare Corporation's (NASDAQ:ADUS) P/E

Sep 18
Some Confidence Is Lacking In Addus HomeCare Corporation's (NASDAQ:ADUS) P/E
author-image

Calculated Acquisitions And Financial Health Drive Positive Growth In Personal Care Market

Strategic financial management, including a successful stock offering and debt clearance, positions Addus HomeCare for growth and acquisitions, enhancing shareholder value.

There May Be Underlying Issues With The Quality Of Addus HomeCare's (NASDAQ:ADUS) Earnings

Aug 14
There May Be Underlying Issues With The Quality Of Addus HomeCare's (NASDAQ:ADUS) Earnings

Is There Now An Opportunity In Addus HomeCare Corporation (NASDAQ:ADUS)?

Jul 14
Is There Now An Opportunity In Addus HomeCare Corporation (NASDAQ:ADUS)?

Addus HomeCare Corporation's (NASDAQ:ADUS) Share Price Could Signal Some Risk

Jun 13
Addus HomeCare Corporation's (NASDAQ:ADUS) Share Price Could Signal Some Risk

Addus HomeCare: Adding More Care

Jun 12

Calculating The Fair Value Of Addus HomeCare Corporation (NASDAQ:ADUS)

Jun 01
Calculating The Fair Value Of Addus HomeCare Corporation (NASDAQ:ADUS)

Here's Why We Think Addus HomeCare (NASDAQ:ADUS) Might Deserve Your Attention Today

May 08
Here's Why We Think Addus HomeCare (NASDAQ:ADUS) Might Deserve Your Attention Today

Is Addus HomeCare (NASDAQ:ADUS) Using Too Much Debt?

Apr 26
Is Addus HomeCare (NASDAQ:ADUS) Using Too Much Debt?

At US$101, Is Addus HomeCare Corporation (NASDAQ:ADUS) Worth Looking At Closely?

Mar 22
At US$101, Is Addus HomeCare Corporation (NASDAQ:ADUS) Worth Looking At Closely?

Investors Will Want Addus HomeCare's (NASDAQ:ADUS) Growth In ROCE To Persist

Feb 25
Investors Will Want Addus HomeCare's (NASDAQ:ADUS) Growth In ROCE To Persist

Addus HomeCare Corporation's (NASDAQ:ADUS) P/E Still Appears To Be Reasonable

Feb 10
Addus HomeCare Corporation's (NASDAQ:ADUS) P/E Still Appears To Be Reasonable

Is Addus HomeCare (NASDAQ:ADUS) A Risky Investment?

Jan 15
Is Addus HomeCare (NASDAQ:ADUS) A Risky Investment?

An Intrinsic Calculation For Addus HomeCare Corporation (NASDAQ:ADUS) Suggests It's 27% Undervalued

Dec 30
An Intrinsic Calculation For Addus HomeCare Corporation (NASDAQ:ADUS) Suggests It's 27% Undervalued

Addus HomeCare (NASDAQ:ADUS) Could Easily Take On More Debt

Oct 05
Addus HomeCare (NASDAQ:ADUS) Could Easily Take On More Debt

At US$83.81, Is It Time To Put Addus HomeCare Corporation (NASDAQ:ADUS) On Your Watch List?

Sep 06
At US$83.81, Is It Time To Put Addus HomeCare Corporation (NASDAQ:ADUS) On Your Watch List?

Return Trends At Addus HomeCare (NASDAQ:ADUS) Aren't Appealing

Aug 18
Return Trends At Addus HomeCare (NASDAQ:ADUS) Aren't Appealing

If EPS Growth Is Important To You, Addus HomeCare (NASDAQ:ADUS) Presents An Opportunity

Jul 06
If EPS Growth Is Important To You, Addus HomeCare (NASDAQ:ADUS) Presents An Opportunity

We Think Addus HomeCare (NASDAQ:ADUS) Can Manage Its Debt With Ease

Jun 03
We Think Addus HomeCare (NASDAQ:ADUS) Can Manage Its Debt With Ease

Returns On Capital At Addus HomeCare (NASDAQ:ADUS) Have Stalled

May 13
Returns On Capital At Addus HomeCare (NASDAQ:ADUS) Have Stalled

Is It Time To Consider Buying Addus HomeCare Corporation (NASDAQ:ADUS)?

Apr 29
Is It Time To Consider Buying Addus HomeCare Corporation (NASDAQ:ADUS)?

A Look At The Fair Value Of Addus HomeCare Corporation (NASDAQ:ADUS)

Mar 30
A Look At The Fair Value Of Addus HomeCare Corporation (NASDAQ:ADUS)

We Think Addus HomeCare (NASDAQ:ADUS) Can Manage Its Debt With Ease

Feb 06
We Think Addus HomeCare (NASDAQ:ADUS) Can Manage Its Debt With Ease

Is Now An Opportune Moment To Examine Addus HomeCare Corporation (NASDAQ:ADUS)?

Jan 24
Is Now An Opportune Moment To Examine Addus HomeCare Corporation (NASDAQ:ADUS)?

Addus HomeCare (NASDAQ:ADUS) May Have Issues Allocating Its Capital

Jan 12
Addus HomeCare (NASDAQ:ADUS) May Have Issues Allocating Its Capital

Is Now The Time To Put Addus HomeCare (NASDAQ:ADUS) On Your Watchlist?

Oct 26
Is Now The Time To Put Addus HomeCare (NASDAQ:ADUS) On Your Watchlist?

Rendement voor aandeelhouders

ADUSUS HealthcareUS Markt
7D1.9%1.9%3.4%
1Y-0.8%-18.1%13.7%

Rendement versus industrie: ADUS overtrof de US Healthcare industrie, die het afgelopen jaar een rendement -18.1 % opleverde.

Rendement versus markt: ADUS presteerde slechter dan US Market, dat het afgelopen jaar een rendement van 13.7 % opleverde.

Prijsvolatiliteit

Is ADUS's price volatile compared to industry and market?
ADUS volatility
ADUS Average Weekly Movement3.9%
Healthcare Industry Average Movement7.3%
Market Average Movement7.7%
10% most volatile stocks in US Market17.4%
10% least volatile stocks in US Market4.0%

Stabiele aandelenkoers: ADUS heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend vergeleken met de US markt.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 4% ) van ADUS is het afgelopen jaar stabiel geweest.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
197927,934R. Allisonwww.addus.com

Addus HomeCare Corporation biedt, samen met haar dochterondernemingen, persoonlijke verzorging aan ouderen, chronisch zieken, gehandicapten en personen die het risico lopen opgenomen te worden in een ziekenhuis of instelling in de Verenigde Staten. Het is actief via drie segmenten: Persoonlijke Verzorging, Hospice en Thuiszorg. Het segment Persoonlijke Verzorging biedt niet-medische hulp bij activiteiten van het dagelijks leven.

Addus HomeCare Corporation Samenvatting

Hoe verhouden de winst en inkomsten van Addus HomeCare zich tot de beurswaarde?
ADUS fundamentele statistieken
MarktkapitalisatieUS$2.09b
Inkomsten(TTM)US$79.00m
Inkomsten(TTM)US$1.21b
26.5x
Koers/Winstverhouding
1.7x
P/S-verhouding

Is ADUS overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
ADUS resultatenrekening (TTM)
InkomstenUS$1.21b
Kosten van inkomstenUS$817.04m
BrutowinstUS$394.52m
Overige uitgavenUS$315.53m
InkomstenUS$79.00m

Laatst gerapporteerde inkomsten

Mar 31, 2025

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)4.35
Brutomarge32.56%
Nettowinstmarge6.52%
Schuld/Eigen Vermogen Verhouding20.0%

Hoe presteerde ADUS op de lange termijn?

Bekijk historische prestaties en vergelijking

Bedrijfsanalyse en status van financiële gegevens

GegevensLaatst bijgewerkt (UTC-tijd)
Bedrijfsanalyse2025/06/30 03:47
Aandelenkoers aan het einde van de dag2025/06/30 00:00
Inkomsten2025/03/31
Jaarlijkse inkomsten2024/12/31

Gegevensbronnen

De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.

PakketGegevensTijdframeVoorbeeld Amerikaanse bron *
Financiële gegevens bedrijf10 jaar
  • Resultatenrekening
  • Kasstroomoverzicht
  • Balans
Consensus schattingen analisten+3 jaar
  • Financiële prognoses
  • Koersdoelen analisten
Marktprijzen30 jaar
  • Aandelenprijzen
  • Dividenden, splitsingen en acties
Eigendom10 jaar
  • Top aandeelhouders
  • Handel met voorkennis
Beheer10 jaar
  • Leiderschapsteam
  • Raad van bestuur
Belangrijkste ontwikkelingen10 jaar
  • Bedrijfsaankondigingen

* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.

Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.

Analysemodel en Snowflake

Details van het analysemodel dat is gebruikt om dit rapport te genereren, zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen voor het gebruik van onze rapporten en tutorials op Youtube.

Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.

Industrie en sector

Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.

Bronnen van analisten

Addus HomeCare Corporation wordt gevolgd door 20 analisten. 11 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.

AnalistInstelling
Brian HoffmanAvondale Partners
Matthew GillmorBaird
Andrew MokBarclays